Khattar Jack A.
Supernus Pharmaceuticals, Inc. · President
Khattar Jack A. is listed in filings as President at Supernus Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 16, 2026, including sale activity. Recent filings connect the profile to Supernus Pharmaceuticals, Inc. (SUPN), scPharmaceuticals Inc. (SCPH), and Cognition Therapeutics, Inc. (CGTX). The current snapshot covers public activity from Jun 13, 2024 to Mar 16, 2026. Reported amounts are shown as $726.7K to $1.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $6.2k120 shares | SellMar 13, 2026 | $51.75 | $48.21 | |
| $548k10.7k shares | SellMar 13, 2026 | $51.00 | $48.21 | |
| $1M24.1k shares | SellMar 13, 2026 | $50.09 | $48.21 |